BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9753234)

  • 1. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
    Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
    Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
    Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
    Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
    Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
    J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
    Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
    J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
    Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
    Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
    Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of ulcer healing and rebamipide].
    Fujiwara Y; Higuchi K; Tominaga K; Watanabe T; Arakawa T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():397-400. PubMed ID: 16363567
    [No Abstract]   [Full Text] [Related]  

  • 13. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
    Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK
    N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
    Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
    Labenz J; Rühl GH; Bertrams J; Börsch G
    Am J Gastroenterol; 1994 May; 89(5):726-30. PubMed ID: 8172146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.
    Axon AT; O'Moráin CA; Bardhan KD; Crowe JP; Beattie AD; Thompson RP; Smith PM; Hollanders FD; Baron JH; Lynch DA; Dixon MF; Tompkins DS; Birrell H; Gillon KR
    BMJ; 1997 Feb; 314(7080):565-8. PubMed ID: 9055715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study.
    Higuchi K; Takeuchi T; Uedo N; Takeuchi Y; Naito Y; Yagi N; Tominaga K; Machida H; Tamada T; Morita Y; Yazumi S; Yamao J; Iguchi M; Azuma T
    Gastric Cancer; 2015 Jul; 18(3):612-7. PubMed ID: 25098924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of gastric ulcer recurrence with tetraprenylacetone.
    Nagasawa Y; Tatsuta M; Iishi H; Ishiguro S
    Scand J Gastroenterol; 1998 Jan; 33(1):44-8. PubMed ID: 9489907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.